Xcout Intel
Cyrano Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Cyrano Therapeutics, Inc. among biotechnology companies — ranked by similarity to what Cyrano Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Cyrano Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Cyrano Therapeutics, Inc.
Cyrano Therapeutics, Inc. is a regenerative medicine company headquartered in Delray Beach, Florida. The clinical-stage firm focuses on developing specialized pharmaceutical treatments and therapies for conditions related to smell loss.
Cyrano Therapeutics, Inc. at a glance
Cyrano Therapeutics, Inc. is a biotechnology company headquartered in United States. It has raised at least $16.1M across the 3 funding rounds on record. Its most recent funding round, Series B, raised $9M in January 2024. Xcout tracks 10 named people at Cyrano Therapeutics, Inc., including Ron Kuppersmith (Chief Clinical Advisor).
Cyrano Therapeutics, Inc. leadership
- Ron KuppersmithChief Clinical Advisor
- Rick GeoffrionFounder, President and CEO & Board Member
- Krista GeoffrionVP of Clinical Affairs
- Joe SmithHead of Business Development
- Michael LustyHead of CMC
- Michaela KennedyController
4 more named people on record for Cyrano Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Cyrano Therapeutics, Inc. funding rounds
At least $16.1M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $9M | 4 named | |
| — | $3M | 4 named | |
| SEC Form D filing | $4.1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Cyrano Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Cyrano Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
CiRC Biosciences is a privately held regenerative medicine and cell therapy company founded in 2019 and based in Chicago, Illinois, focused on developing cellular reprogramming solutions for degenerative diseases.
Similar biotechnology company
ChemoSensoryX Biosciences SA is a biotechnology company that provides discovery products and services related to chemical communications mediated by human olfactory and taste receptors. Utilizing a proprietary technology platform and screening facilities, the company develops solutions for odor and taste management, including malodor blockers, pleasant odor enhancers, and applications for flavors, fragrances, and drug discovery.
Similar biotechnology company
Spiral Therapeutics Inc. is a clinical-stage pharmaceutical company based in South San Francisco, California, focused on delivering targeted therapies for inner ear conditions.
Similar biotechnology company
GenrAb, Inc. is a Dallas, Texas-based developer focused on creating first-in-class neuroprotective therapies. The company recently completed significant private financing to accelerate the development of its therapeutic pipeline.
Similar biotechnology company
Cynata Therapeutics is a biotechnology research company headquartered in Cremorne, Australia, focused on therapeutic products and stem cell technology.
Healthcare & Life Sciences
Rinri Therapeutics is a private biotechnology company headquartered in Sheffield, South Yorkshire, United Kingdom. Founded in 2018, the firm focuses on regenerative medicine research to develop first-in-class therapeutics for treating hearing loss and neurological conditions.
Similar biotechnology company
Cognition Therapeutics, Inc. is a public, clinical-stage biopharmaceutical company founded in 2007 and headquartered in Purchase, New York. The company develops therapies designed to protect neurons and advance treatments for patients living with age-related neurodegenerative diseases.
Similar biotechnology company
Eluciderm Inc. is a clinical-stage regenerative medicine small-molecule pharmaceutical company that uses a selective multi-PARP modulation platform to alter the body’s response to inflammation and injury. The company develops therapeutics designed to enable organized tissue regeneration, enhance wound healing, and minimize scarring following trauma.
Similar biotechnology company
Sironax is a biopharmaceutical company committed to developing new treatments by targeting underlying contributors of degeneration, including neurodegenerative, inflammatory, and metabolic disorders.
Biotech
NervGen Pharma Corp. is a biotechnology enterprise currently in its clinical development phase, focused on devising therapeutic solutions for nerve injuries and progressive neurodegenerative diseases. Their innovative approach centers on deactivating the natural biological mechanisms that typically impede the nervous system's ability to repair itself.
Similar biotechnology company
CuraSen Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies to treat neurodegenerative diseases by targeting specific receptor systems in the brain. The company's scientific approach focuses on restoring neurovascular and neuronal function to serve patients suffering from conditions such as Parkinson's disease and other neurodegenerative disorders.
Similar biotechnology company
Longeveron Inc. is a biotechnology company currently in the clinical development stage, dedicated to pioneering cell-based therapies. These treatments are designed to address both age-related conditions and various critical, life-threatening illnesses. The company's primary investigational product is LOMECEL-B, a sophisticated cellular therapy. This product is created from medicinal signaling cells that are cultivated and expanded after being harvested from the bone marrow of healthy young adult donors. Longeveron is actively conducting Phase 1 and Phase 2 clinical trials to evaluate LOMECEL-B's potential across a diverse range of indications. These include age-related frailty, Alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome (ARDS), and hypoplastic left heart syndrome (HLHS). Established in 2014, Longeveron Inc. operates from its headquarters in Miami, Florida.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Cyrano Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Cyrano Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →